Q
Qixiao Zhai
Researcher at Jiangnan University
Publications - 247
Citations - 4540
Qixiao Zhai is an academic researcher from Jiangnan University. The author has contributed to research in topics: Gut flora & Medicine. The author has an hindex of 25, co-authored 173 publications receiving 2183 citations. Previous affiliations of Qixiao Zhai include Norwich University.
Papers
More filters
Journal ArticleDOI
Dietary strategies for the treatment of cadmium and lead toxicity.
TL;DR: The evidence for protective effects of essential metals, vitamins, edible plants, phytochemicals, probiotics and other dietary supplements against Cd and Pb toxicity is reviewed and the proposed possible mechanisms are described.
Journal ArticleDOI
A next generation probiotic, Akkermansia muciniphila
TL;DR: The biological characterization of A. muciniphia is described, the factors that influence its colonization of the intestinal tract are described, and the current state of knowledge on its role in host health and disease is discussed.
Journal ArticleDOI
Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier.
TL;DR: Probiotics’ regulation of the intestinal epithelium via their surface compounds is summarized and the molecular interaction between these bacteria and the gut epithelial barrier is discussed.
Journal ArticleDOI
Protective Effects of Lactobacillus plantarum CCFM8610 against Acute Cadmium Toxicity in Mice
TL;DR: The results suggested that CCFM8610 is more effective against acute Cadmium toxicity than a simple antioxidant treatment due to its special physiological functions and that it can be considered a new dietary therapeutic strategy against acute cadmiumoxicity.
Journal ArticleDOI
Oral Administration of Probiotics Inhibits Absorption of the Heavy Metal Cadmium by Protecting the Intestinal Barrier
Qixiao Zhai,Qixiao Zhai,Fengwei Tian,Fengwei Tian,Jianxin Zhao,Hao Zhang,Hao Zhang,Arjan Narbad,Wei Chen,Wei Chen,Wei Chen +10 more
TL;DR: Along with initial intestinal Cd sequestration, probiotics can inhibit Cd absorption by protecting the intestinal barrier, and the protection is related to the alleviation of Cd-induced oxidative stress.